Ca2+ elevations in the heart can serve as a signal for augmented energy output from the mitochondria by directly increasing the activity of the electron transport chain and associated dehydrogenases. However, at the same time sustained elevations in Ca2+ that occurs acutely after myocardial infarction injury can cause cardiomyocyte necrotic and apoptotic death through opening of the mitochondrial permeability transition pore (PTP). The mitochondrial Ca2+ uniporter (MCU) complex imports Ca2+ across the inner membrane into the mitochondrial matrix where it can affect both energy production and PTP opening during acute ischemic injury. Hence the MCU complex and many of the more recently described genes that constitute it could be novel therapeutic targets for drug design with the goal of reducing cardiomyocyte death or altering cardiac metabolic performance. The genes that comprise the MCU were only recently identified in the past 4 years; hence the field is still in its infancy with respect to genetically correlating mitochondrial Ca2+ regulation with cardiac physiology and pathophysiology in vivo. Here we propose to use mice lacking many of these key molecular regulators of mitochondrial Ca2+ handling to decode and differentiate between physiological and pathological Ca2+ signals at baseline and with disease. Our overarching goal is to examine how mitochondrial Ca2+ influx and efflux regulates cardiac life, death and metabolism. However, no single cardiac laboratory in our field has the underlying expertise to both characterize the complex biophysics of mitochondrial Ca2+ handling and at the same time employ the necessary mouse genetics and cell biology to truly achieve the stated goals of this project. Hence, we have implemented a seamless collaborative dual-PI proposal that will be 50/50 effort between the Molkentin and Bers laboratory, to wed the very best in mouse molecular genetics and cardiac physiology with innovative assessment of mitochondrial and intracellular Ca2+ imagining and PTP activity, respectively.
Our Aims will be: 1) to characterize the function of the newly identified MCU complex genes as well as other new genes underlying mitochondrial Ca2+ regulation the heart, 2) To assess MCU gene function in underlying cardiac physiology, metabolism and after ischemic injury, and 3) To assess PTP dynamics and the physiologic versus pathophysiologic states of the PTP in regulating mitochondrial Ca2+ and cell death. The 2 PIs have a strong track record of working together with multiple shared publications and joint grants. Hence, they represent an ideal melding of 2 rather divergent laboratory skill sets that are needed to truly understand mitochondrial Ca2+ regulation and its effect on cardiac physiology and disease responsiveness.

Public Health Relevance

The relevance of this application is rooted in the fundamental translational biology of how mitochondrial calcium impacts myocyte death and metabolism, both of which are dramatically altered in heart failure or immediately after myocardial infarctino injury. The proposal will investigate the mechanisms and genes that alter intra-mitochondrial calcium levels. A better understanding of how we might reduce or inhibit dramatic increased in mitochondrial calcium after ischemic injury would lead to novel protective strategies, such that myocytes could be prevented from necrotic death.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL132831-04
Application #
9676907
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Wong, Renee P
Project Start
2016-07-15
Project End
2021-03-31
Budget Start
2019-04-01
Budget End
2021-03-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Thai, Phung N; Daugherty, Daniel J; Frederich, Bert J et al. (2018) Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure. Sci Rep 8:16213
Kwong, Jennifer Q; Huo, Jiuzhou; Bround, Michael J et al. (2018) The mitochondrial calcium uniporter underlies metabolic fuel preference in skeletal muscle. JCI Insight 3:
Correll, Robert N; Makarewich, Catherine A; Zhang, Hongyu et al. (2017) Caveolae-localized L-type Ca2+ channels do not contribute to function or hypertrophic signalling in the mouse heart. Cardiovasc Res 113:749-759
Karch, Jason; Schips, Tobias G; Maliken, Bryan D et al. (2017) Autophagic cell death is dependent on lysosomal membrane permeability through Bax and Bak. Elife 6:
Luongo, Timothy S; Lambert, Jonathan P; Gross, Polina et al. (2017) The mitochondrial Na+/Ca2+ exchanger is essential for Ca2+ homeostasis and viability. Nature 545:93-97